Sobhan Recombinant Protein

Sobhan Recombinant Protein is a prominent Iranian biotechnology company dedicated to the production of high-value biosimilars and recombinant proteins. Founded in 2004 and headquartered in Rasht, the company operates within the Barakat Pharmaceutical Group, one of the largest pharmaceutical conglomerates in the Middle East. Its state-of-the-art manufacturing facilities are equipped for large-scale mammalian cell culture and protein purification under strict GMP standards. The company's primary commercial products include Ziferon, an interferon beta-1a used in the treatment of multiple sclerosis, and Altebrel, a biosimilar etanercept for autoimmune disorders. Sobhan Recombinant Protein focuses on expanding access to advanced biological therapies through local innovation and rigorous quality control.